Brandon Poe - 11 Aug 2026 Form 4 Insider Report for BioStem Technologies, Inc. (BSEM)

Reporting relationship: Chief Financial Officer
Issuer ticker: BSEM
Reported as of: 11 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Aug 2026, 19:30:05 UTC
Prior SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Katherine Gorrell, as Attorney-in-Fact

Key filing fact

Brandon Poe filed Form 4 for BioStem Technologies, Inc. (BSEM) on 20 Aug 2026.

Key facts

This page summarizes Brandon Poe's Form 4 filing for BioStem Technologies, Inc. (BSEM).
2 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 20 Aug 2026, 19:30.

Change

Previous filing in this sequence was filed on 14 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147189 Primary reporting owner

POE BRANDON

Relationship: Chief Financial Officer
Address: C/O BIOSTEM TECHNOLOGIES, INC., 2836 CENTER PORT CIRCLE, POMPANO BEACH
Signature: /s/ Katherine Gorrell, as Attorney-in-Fact
Signature date: 20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSEM transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,634
Change %: +23%
Price: $0.000000^*
Shares after: 56,368
Date: 11 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSEM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -10,634
Change %: -33%
Price: $0.000000^*
Shares after: 21,591
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,634
Exercise price
Footnotes: F3, F5

BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,814
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,814
Exercise price: $6.48
Footnotes: F1

BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 117,401
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 117,401
Exercise price: $5.50
Footnotes: F2

BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,469
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,469
Exercise price
Footnotes: F3, F4

BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 96,909
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 96,909
Exercise price
Footnotes: F3, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These options vest according to the following schedule: 33% vested on August 11, 2026, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F2

These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F4

These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

Footnote F5

These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business days of the applicable transaction date.

Footnote F6

These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

SEC remarks

Exhibit 24 - Power of Attorney